- Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic
-
Lee JE, Yang JH, Nam SJ
- KMID: 2286519
- J Breast Cancer.
- 2011 Jun;14(2):165-166.
- doi: 10.4048/jbc.2011.14.2.165
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Primary Fibrosarcoma of the Breast: A Case Report
-
Lee JY, Kim DB, Kwak BS, Kim EJ
- KMID: 2286517
- J Breast Cancer.
- 2011 Jun;14(2):156-159.
- doi: 10.4048/jbc.2011.14.2.156
A primary fibrosarcoma of the breast is a rare tumor. Here we report on a case of a primary fibrosarcoma of the breast that presented as a palpable left breast... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors and Control Strategies for the Rapidly Rising Rate of Breast Cancer in Korea
-
Park SK, Kim Y, Kang D, Jung EJ, Yoo KY
- KMID: 2286505
- J Breast Cancer.
- 2011 Jun;14(2):79-87.
- doi: 10.4048/jbc.2011.14.2.79
Due to the aging population and tremendous changes in life style over the past decades, cancer has been the leading cause of death in Korea. The incidence rate of breast... -
- CITED
-
- Close
- SHARE
-
- Close
- Ultrasound and Clinicopathological Characteristics of Triple Receptor-Negative Breast Cancers
-
Choi YJ, Seong MH, Choi SH, Kook SH, Kwag HJ, Park YL, Park CH
- KMID: 2286510
- J Breast Cancer.
- 2011 Jun;14(2):119-123.
- doi: 10.4048/jbc.2011.14.2.119
PURPOSE: Triple receptor-negative (TRN) breast cancer is associated with high risk of recurrence and poor prognosis. The present study assessed the clinicopathologic characteristics and ultrasound (US) features of TRN breast... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal Carcinoma In Situ and Invasive Breast Cancer
-
Jeong YJ, Bong JG, Park SH, Choi JH, Oh HK
- KMID: 2286507
- J Breast Cancer.
- 2011 Jun;14(2):96-103.
- doi: 10.4048/jbc.2011.14.2.96
PURPOSE: Adipocytokines, such as leptin, resistin, and adiponectin, are associated with obesity and breast cancer. Several studies have indicated that adipocytokines may influence tumor growth or differentiation. The aims of... -
- CITED
-
- Close
- SHARE
-
- Close
- Ectopic Hidradenoma Papilliferum of the Breast: Ultrasound Finding
-
Kim YJ, Lee JW, Choi SJ, Kim SJ, Kim YJ, Jeon YS, Lee KH
- KMID: 2286516
- J Breast Cancer.
- 2011 Jun;14(2):153-155.
- doi: 10.4048/jbc.2011.14.2.153
Hidradenoma papilliferum (HP) is a benign neoplasm arising from mammary-like glands which typically involves the dermal layer of the female anogenital area. The prognosis for HP is good. Recurrence is... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary Acinic Cell Carcinoma of the Breast: A Case Report with an Immunohistochemical and Ultrastructural Studies
-
Chang ED, Lee EJ, Lee AW, Kim JS, Kang CS
- KMID: 2286518
- J Breast Cancer.
- 2011 Jun;14(2):160-164.
- doi: 10.4048/jbc.2011.14.2.160
Acinic cell carcinoma (ACC) of the breast is extremely rare and is characterized by widespread acinar cell-like differentiation. We report of a 39-year-old woman presented with a palpable breast mass... -
- CITED
-
- Close
- SHARE
-
- Close
- Quality of Life Differences between Younger and Older Breast Cancer Patients
-
Park BW, Lee S, Lee AR, Lee KH, Hwang SY
- KMID: 2286509
- J Breast Cancer.
- 2011 Jun;14(2):112-118.
- doi: 10.4048/jbc.2011.14.2.112
PURPOSE: This study was designed to investigate quality of life (QOL) differences between younger ( or =50 years) breast cancer survivors and to determine the unique effect of age on... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Characteristics Influencing Non-Sentinel Lymph Node Involvement in Clinically Node Negative Patients with Breast Cancer
-
Gurleyik G, Aker F, Aktekin A, Saglam A
- KMID: 2286511
- J Breast Cancer.
- 2011 Jun;14(2):124-128.
- doi: 10.4048/jbc.2011.14.2.124
PURPOSE: The negative sentinel lymph node (SLN) biopsy avoids conventional axillary dissection in patients with breast cancer with clinically negative axilla. Despite negative SLN, there is a risk of leaving... -
- CITED
-
- Close
- SHARE
-
- Close
- D2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast
-
Lee JA, Bae JW, Woo SU, Kim H, Kim CH
- KMID: 2286508
- J Breast Cancer.
- 2011 Jun;14(2):104-111.
- doi: 10.4048/jbc.2011.14.2.104
PURPOSE: Distant metastasis and recurrence are major prognostic factors associated with breast cancer. Both lymphovascular invasion (LVI) and blood vessel invasion (BVI) are important routes for metastasis to regional lymph... -
- CITED
-
- Close
- SHARE
-
- Close
- Overexpression of MMP-9 and HIF-1alpha in Breast Cancer Cells under Hypoxic Conditions
-
Choi JY, Jang YS, Min SY, Song JY
- KMID: 2286506
- J Breast Cancer.
- 2011 Jun;14(2):88-95.
- doi: 10.4048/jbc.2011.14.2.88
PURPOSE: Hypoxia, which is a loss of oxygen in tissues, is a common condition in solid tumors due to the tumor outgrowing existing vasculature. Under hypoxic conditions, hypoxia-inducible factor (HIF)-1alpha... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Fulvestrant in Heavily Pretreated Postmenopausal Women with Advanced Breast Cancer: A Preliminary Report
-
Yoo C, Kim SB, Ahn JH, Jung KH, Ahn Y, Gong G, Kim HH, Kim HJ, Son BH, Ahn SH
- KMID: 2286513
- J Breast Cancer.
- 2011 Jun;14(2):135-139.
- doi: 10.4048/jbc.2011.14.2.135
PURPOSE: Fulvestrant, a potent estrogen receptor (ER) antagonist with a novel mechanism of action, has shown efficacy in pretreated patients with advanced breast cancer. We assessed the efficacy and tolerability... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Initial Axillary Lymph Node Metastasis after Primary Systemic Therapy
-
Kang E, Chung IY, Han SA, Kim SM, Jang M, Lyou CY, Park SY, Kim JH, Kim YJ, Kim SW
- KMID: 2286515
- J Breast Cancer.
- 2011 Jun;14(2):147-152.
- doi: 10.4048/jbc.2011.14.2.147
PURPOSE: Primary systemic therapy (PST) downstages up to 40% of initial documented axillary lymph node (ALN) metastases in breast cancer. The current surgical treatment after PST consists of breast tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
-
Lee YR, Huh SJ, Lee DH, Yoon HH, Seol YM, Choi YJ, Kwon KA, Lee S, Oh SY, Kim SH, Kim HJ, Kwon HC
- KMID: 2286514
- J Breast Cancer.
- 2011 Jun;14(2):140-146.
- doi: 10.4048/jbc.2011.14.2.140
PURPOSE: The role of first-line trastuzumab-based therapy has been firmly established in patients with human epidermal growth factor receptor-2 (HER2) positive metastatic breast cancer. In this trial, we evaluated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
-
Gwak G, Kim JY, Park K, Shin YJ, Cho H, Park SJ, Yang GH, Bae BN, Kim KW, Han S
- KMID: 2286512
- J Breast Cancer.
- 2011 Jun;14(2):129-134.
- doi: 10.4048/jbc.2011.14.2.129
PURPOSE: This study was performed to compare the therapeutic efficacy and toxicity of doxorubicin plus docetaxel neoadjuvant chemotherapy (NC) with doxorubicin plus vinorelbine NC. METHODS: Fifty-three patients underwent 4 cycles of... -
- CITED
-
- Close
- SHARE
-
- Close
